- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Significant Ownership of COLUMN GROUP II, LP
- Signature - Title
- /s/ James Evangelista, Attorney-in-Fact - James Evangelista, Attorney-in-Fact
- Location
- San Francisco, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by COLUMN GROUP II, LP.
Follow Filing Activity
Follow COLUMN GROUP II, LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of COLUMN GROUP II, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics, Inc. | Common Stock, $0.0001 par value | 4.9% | $1,395,126 | 1,603,593 | Peter Svennilson | 23 Dec 2024 | ||
| ORIC | ORIC Pharmaceuticals, Inc. | Common Stock, $0.0001 par value per share | 3.7% | $48,612,534 | 3,644,118 | Peter Svennilson | 30 Sep 2025 |
Schedules 13D/G Reported by COLUMN GROUP II, LP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.